We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Dental examination and appropriate preventive dentistry should be considered before treatment, especially for patients also treated with an intravenous bisphosphonate.
Maintenance doses of brolucizumab (after the first 3 doses) should not be given at intervals of less than 8 weeks apart.
As with any medicine, the MHRA will keep the safety and effectiveness of sevabertinib under close review.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Information for patients, public and healthcare professionals.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Guidance on labelling for medicinal products used in clinical trials.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
A summary of letters and recent medicine recalls and notifications sent to healthcare professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).